🇺🇸 FDA
Patent

US 11603542

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

granted A61KA61K31/713A61K45/06

Quick answer

US patent 11603542 (Compositions and methods of treating amyotrophic lateral sclerosis (ALS)) held by VOYAGER THERAPEUTICS, INC. expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/713, A61K45/06, A61P, A61P25/28